Development of a Preterm Birth Risk Prediction Model Based on CCL28 Biomarker Selection and Multidimensional Data Integration
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70175 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Yingying Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Premature Birth, Biomarkers, Chemokines, CC, Placenta. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Clinical Research Project of Guangdong Women and Children Hospital.
Abstract (Originalsprache)
Aim
This study aimed to identify potential biomarkers for preterm birth (PTB) and construct a multidimensional risk prediction model integrating clinical and proteomic data, with a focus on CCL28. Materials and Methods Pregnant women were enrolled and categorized into PTB and term birth (TB) groups. Plasma and placental samples were analyzed using OLINK proteomics, ELISA, and immunohistochemistry. Logistic regression and nomogram modeling were employed to assess predictive markers, while ROC curve analysis was used to evaluate model performance.
Results
Proteomic analysis revealed significantly lower CCL28 levels in PTB compared to TB ( p < 0.01), which was validated by ELISA ( p < 0.0001). Immunohistochemistry confirmed reduced CCL28 expression in PTB placental tissue. Multivariate logistic regression identified CCL28 as an independent predictor of PTB (OR = 0.150, p = 0.01). The developed nomogram, incorporating CCL28 levels and clinical variables, demonstrated strong predictive ability (AUC = 0.841).
Conclusion
CCL28 was identified as a key biomarker for PTB prediction. The integrated prediction model enhanced early risk assessment, providing a valuable tool for targeted clinical interventions in high‐risk pregnancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Medical University, Guangzhou, China.
- Department of Rehabilitation, Guangdong Women and Children Hospital, Guangzhou, China.
- Department of Obstetrics, Guangdong Women and Children Hospital, Guangzhou, China.
ORCID-Profile: Yingying Li
Förderung
- Clinical Research Project of Guangdong Women and Children Hospital
Zitieren
APA
Li, Y., Xu, N., Zhang, J., & Liu, G. (2025). Development of a Preterm Birth Risk Prediction Model Based on CCL28 Biomarker Selection and Multidimensional Data Integration. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70175
Vancouver
Li Y, Xu N, Zhang J, Liu G. Development of a Preterm Birth Risk Prediction Model Based on CCL28 Biomarker Selection and Multidimensional Data Integration. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70175
BibTeX
@article{Li2025,
author = {Li, Yingying and Xu, Ning and Zhang, Jie and Liu, Guocheng},
title = {Development of a Preterm Birth Risk Prediction Model Based on CCL28 Biomarker Selection and Multidimensional Data Integration},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70175}
}
EUVIMED